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Abstract 
 
A basic material of polymethyl methacrylate (PMMA) acrylic resins is methyl methacrylate (MMA) monomer and 
widely used in dental medicine. It is primarily used for removable orthodontic, partial and full denture appliances, and 
also for dental fillings. The facts and results of the previous studies showed that MMA might act as irritant in certain 
concentration, and also as immunogen or allergen. This study examined the immunopathogenesis of oral mucosal tissue 
destruction in patients exposed to MMA, by detecting the concentrations of plasma IL-4, IFN-γ, TNF-α, serum IgG and 
IgE specific to MMA that mediated irritation and allergic reactions. The general objective of this research was to examine 
the immunopathogenesis of oral mucosal tissue destruction in patients exposed to MMA. The study used observasional 
case control study design. Laboratory tests for all samples were assessing plasma IL-4, IFN-γ and TNF-α using direct 
sandwich ELISA technique. Serum IgG and IgE specific to MMA were assessed by indirect ELISA. It was concluded 
that MMA is immunogenic in patients exposed to MMA that can induce IgG anti-MMA. Furthermore, this study also 
proved that immunopathogenesis of oral mucosal tissue destruction in patients exposed to MMA did occur through 
irritation and type I hypersensitivity reaction mediated by IgE, but occurred through type IV hypersensitivity reactions. 
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INTRODUCTION  
 
    Methyl methacrylate (MMA) monomer is a basic 
material of polymethyl methacrylate (PMMA) 
acrylic resins widely used in dental medicine. It is 
primarily used for removable orthodontic appli-
ances, partial and full denture appliances, and also 
for dental fillings. Many clinical facts showed that 
MMA may cause irritation and hypersensitivity 
reaction in oral mucosa with some clinical symp-
toms such as hyperemia, mucosal edema, painful 
oral mucosa, and burning mouth.1-4 The incidence of 
clinical symptom in patients exposed to MMA is 
0.5-1%.1 However, immunopathogenesis of oral 
mucosal tissue destruction in patients exposed to 
MMA has not been clear. 
    MMA penetration into mucosal tissue is possible, 
because its chemical structure is lipophylic that 
enables MMA to penetrate the barrier of oral mu-
cosal tissue. The facts and results of the previous 
studies showed that MMA might act as irritant in 
certain concentration, and also as immunogen or 
allergen.5-9 However, the immunopathogenesis of 
oral mucosal tissue destruction through irritation and 
hypersensitivity reaction in patients exposed to 
MMA has not been clear.   
    The preliminary study proved that MMA can in-
duce a secondary immune response in local rabbit 
immunized with MMA, by examining the IgG anti-
MMA production pattern in certain period.10,11 This 
study examined the immunopathogenesis of oral 
mucosal tissue destruction in patients exposed to 
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MMA, by detecting the concentrations of plasma 
IL-4, IFN-γ, TNF-α, serum IgG and IgE specific to 
MMA that mediated irritation and hypersensitivity 
reactions.  
    Hopefully, the results of this study could be as 
scientific information about irritation and hyper-
sensitivity reaction in patients exposed to MMA. So, 
this study can be used as a reason to find a new 
material for sensitive patients to MMA, as alterna-
tive dental material.   
 
MATERIALS AND METHODS  
 
    This study used observasional case control study 
design. Samples were devided into two groups, i.e. 
control and case group.11  
    Control group was MMA unexposed patients 
without inflammation symptom. Inclusion criteria 
for a control group, patients who were no MMA 
exposed or no denture wore are man or woman with 
no clinical symptoms: hyperemia; local inflam-
mation, pain, and burning mouth, ulcer, no anti-
allergic drug consuming. Case group was first 
MMA exposed patients with local inflammation 
symptoms. Inclusion criteria for a case group, pa-
tients who were MMA exposed for the first time  are 
women or man who wore the partial or full denture 
with the age 35-60 years; normal weight; with 
clinical symptoms: hyperemia; local inflammation, 
vesicular, and burning mouth, ulcer, no anti-allergic 
drug consuming. Total samples of each group were 
8 patients from Airlangga University Prosthodontic 
Dental Clinic.  
    Laboratory tests for all samples were assessing 
plasma IL-4, IFN-γ and TNF-α using direct sand-
wich ELISA technique. Serum IgG and IgE specific 
to MMA were assessed by indirect ELISA (method 
by BrenderMed System©).  
 
RESULTS    
 
    Clinical identification has been found in patients 
who wore the full denture were hyperemia, mucosal 
edema, vesicular, and burning mouth (Figure 1). 
 
 
 
 
 
 
 
 
 
Figure 1. Oedematous, hyperemia, vesicula, and  
burning mouth 
    The result of  IgG specific to MMA detection 
showed that the case group has  positive result with 
absorbance scores between 0.035-0.0360 (Table 1).  
 
Table 1. Absorbance specific IgG in patients ex-
posed to MMA 
  
No.  
Patient 
absorbance 
specific IgG at  
450 nm 
Mean 
control 
Positif  
point  
Patient 
Pos 
/Neg 
1.    0,0350 0,01 0,02 Pos
 
2.    0,0300 0,01 0,02 Pos 
3.    0,0360 0,01 0,02 Pos 
4.    0,0530 0,01 0,02 Pos 
5.    0,0450 0,01 0,02 Pos 
6.    0,0510 0,01 0,02 Pos 
7.    0,0410 0,01 0,02 Pos 
8.    0,0510 0,01 0,02 Pos 
 
Table 2. Absorbance specific  IgE  in patients  ex-
posed to MMA 
 
No. 
Patient 
absorbance 
specific 
IgE at  
450 nm 
Mean 
control 
Positif  
point 
Patient   
Pos 
/Neg 
1. 0,1110 0,13 0,26 Neg 
2. 0,1270 0,13 0,26 Neg 
3. 0,1280 0,13 0,26 Neg 
4. 0,1450 0,13 0,26 Neg 
5. 0,1280 0,13 0,26 Neg 
6. 0,1540 0,13 0,26 Neg 
7. 0,1590 0,13 0,26 Neg 
8. 0,0991 0,13 0,26 Neg 
 
Table 3. Consentration plasma IL-4 (pg/ml) between 
patienst exposed to MMA and controls  
 
    Furthermore, the IgE spesific to MMA has 
negative  result in case group.   Absorbance scores 
IgE specific to MMA in case group are between 
0,0991-0,1590. 
No. 
Plasma  
Controls Patients 
1. 10,43 58,70 
2. 14,78 66,65 
3. 24,35 83,48 
4. 23,91 82,17 
5. 24,78 70,00 
6. 20,87 60,00 
7. 20,00 58,26 
8. 23,48 59,13 
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Table 4. Independent t test for plasma IL-4 between 
patients exposed to MMA and controls  
 
 Plasma 
 Controls Patients 
Mean 20,32 pg/ml 67,30 pg/ml 
Standard 
deviation 
5,18   pg/ml 10,46 pg/ml 
t count 11,379 
p 0,01 * 
*Significant (p< 0,05) 
 
Table 5. Consentration plasma TNF-α (pg/ml) bet-
ween patients exposed to MMA and con-
trols 
 
No.  Plasma 
Controls Patients 
1. 11,30 23,67 
2. 9,16 23,98 
3. 9,93 23,67 
4. 11,94 24,43 
5. 10,69 28,41 
6. 10,38 29,17 
7. 9,16 28,41 
8. 9,16 28,86 
 
Table 6. Independent t test for variabel plasma                
TNF-α between patients exposed to MMA               
and controls 
 
 Plasma 
 Controls Patients 
Mean 35,52 pg/ml 90,77 pg/ml 
Standard 
deviation  
2,92 pg/ml 20,45 pg/ml 
t count 16,371 
p 0,01* 
*Significant (p< 0,05) 
 
Table 7. Consentration plasma IFN-γ (pg/ml) in 
patients exposed to MMA and controls 
 
No.  Plasma 
Controls Patients 
1. 54,76 84,76 
2. 52,38 81,83 
3. 55,24 95,71 
4. 53,33 94,29 
5. 52,86 82,86 
6. 57,17 80,48 
7. 53,81 78,10 
8. 50,00 79,05 
 
    The plasma IL-4 concentration in case group 
between 189.13-253.04 pg/ml (Tabel 3) and this is 
significantly upregulated (p<0.05) (Table 4). 
Although, plasma IL-4 significantly upregulated, but 
there is no positive result of IgE specific to MMA. 
    The plasma TNF-α concentration in case group is 
higher than in control group. The plasma TNF-α 
concentration in case group is between 23.67- 29.17 
pg/ml and  in control group is between 9.16 -11.94 
pg/ml. This is significantly  different between two 
groups (p<0,05) (Table 5 and 6).   
    Furthermore,  the plasma IFN-γ concentration in 
case group is between 78.10 – 95.71 pg/ml  and  in 
control group is between 50.00 – 57.17 pg/ml. T-test 
analysis showed this is significantly upregulated 
(p<0,05) (Table 7 and 8).  
 
Table 8. Independent t test for plasma  IFN-γ               
between patients exposed to MMA and               
controls 
 
 Plasma 
 Controls Patients 
Mean 35,52 pg/ml 90,77 pg/ml 
Standard 
deviation  
2,93  pg/ml 20,46 pg/ml 
t count 12,378 
p 0,01 * 
*Significant (p< 0,05) 
 
DISCUSSION  
 
    Irritant reaction or contact hypersensitivity, pre-
viously thought to be monomorphous process, is 
now considered a complex biological syndrome 
with a diverse pathophysiology, natural history and 
clinical appearence. Numerous factors determine 
whether a particular substance will caused irritant 
and inflamation in given individual. Likewise, the 
type of exogenous stimulus may influence the re-
action. Although certain topically applied irritancy 
by stripping of the skin exhibited no inflammatory 
cell infiltration during initial 24 hours.13,14  
    The role of cytokines has been known as phatho-
mechanism of cell-mediated hypersensitivity contact 
dermatitis and contact irritant. The cytokines regu-
late each other by competition, interaction and 
mutual induction in series of lymphokine cascades 
and circuits with possitive or negative feedback 
effect.13,14  
    The result of this study showed  that MMA can 
induce immune response  with the production of 
IgG specific to MMA. It means that MMA is im-
munogenic in patients exposed to MMA (Table 1).  
    Previous study reported that membrane distur-
bance caused by monomer MMA. MMA showed 
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liposomes changes in liposomes characterized by 
membrane disturbance. It was suggested that MMA 
intercalated into the cellular membrane and moved 
through their lipid phase and injured the cells in low 
concentation. This finding showed a cooperativity 
between methyl chain and liposomes of membrane 
lipid bilayer. However, MMA penetrates deeply into 
the interior membrane due to lipophylicity and 
caused injury to cells.16,17 
    Preleminary in vivo study proved that MMA can 
induce immune response by characterizing IgG 
specific to MMA in local rabbit after immunisizing 
with MMA. First booster (day 28 after first immu-
nization) increased IgG anti-MMA production and 
achieved its peak on day 42, after that began to 
decrease gradually until day 49. Second booster 
given on day 52 increased IgG anti-MMA pro-
duction and achieved its peak on day 80, and after 
that began to decrease gradually until day 87. The 
peak of IgG anti-MMA production after the second 
booster was higher than the first booster.10,11  
    Methyl methacrylate could be conjugated to 
protein host as protein carrier. Conjugation of MMA 
with protein carrier through non-covalen amino 
hydophobic acid, i.e. alanin, leusyn, tyrosin, feny-
lalanin, and valyn.18,19  
    This study showed that IgE anti-MMA was ne-
gative in patients exposed to MMA (Table 2). 
Plasma IL-4 in patients exposed to MMA were 
significantly upregulated (p<0.05) (Table 3 and 4). 
Although, plasma IL-4 significantly upregulated, but 
there was no positive result of IgE specific to MMA. 
It can be concluded that immunopathogenesis of 
oral mucosal tissue destruction in patients exposed 
to MMA did not occur through type I hypersensi-
tivity reaction mediated by IgE. The profile of 
secreted cytokines is highly dependent on the 
particular type of T cells in hypersensitivity reaction, 
it seems that this specific response of T cells to 
antigenic challenge defines the nature of the 
immune reponse.20,21  In 1986 Mosmann et al. (cit. 
Effendy et.al.)13 began a conconseptual revolution in 
immunology by divining T helper (Th) cells into 
two populations with contrasting and cross-
regulating cytokine profile: Th1 and Th2 cytokine. 
The new paradigm was accepted in every area  of 
immunologic  and  infectious  disease.  For instance, 
contact sensitivity has generally been regarded as 
specific Th1-mediated process.22-25 
    To day, however, there is good evidence that both 
Th1 and Th2 cytokines, for example, are primarily 
involved in sensitivity contact, suggesting that cer-
tain prior distinctions in molecular mechanisms of 
cell-mediated delayed type hypersensitivity or 
sensitivity contact requires revisiting.15,23  
    The results of this study were significantly up-  
regulated TNF-α (p<0,05) (Table 5 and 6). TNF-α 
secretion could be upregulated by type IV and 
irritant reaction. It means that MMA caused delayed 
type hypersensitivity (type IV hipersensitivity) and 
suggested that upregualted via protein kinase C-
dependent increase in promoter activity or induced 
keratinocytes without intermediate Langerhans cell 
(LC)-derived signals.26  
    Furthermore, the results of the study showed that 
there were also significantly upregulated IL-4 and 
IFN-γ (Table 3 and 7). Enk and Katz27 showed a dis-
tinct cascade of epidermal cytokines in iritant 
reaction caused by irritant (i.e. chemical substance) 
when compared with that in early phase of hyper-
sensitivity reaction (type I hypersensitivity) induced 
by allergen.  Kondo et. al.28 reported that the upregu-
lated TNF-α, because of  LC-derived cytokine has 
been thought to be specific for sensitivity contact. 
Furthermore, it explaned that allergen activated 
lymph node cells (LNC). 
    If immunopathogenesis of oral mucosal tissue 
destruction in patients exposed to MMA happened 
through irritation reaction, there would be signifi-
cantly upregulated (p<0.05) of plasma TNF-α, 
without significantly upregulated (p>0.05) of IL-4 
and IFN-γ. However, the results of this study 
showed that there were significant upregulated of 
plasma TNF-α, IL-4 and IFN-γ. 
    Keratinocytes are not only involved in irritant 
reaction but also in hypersensitivity contact, through 
the synthesis and the releasing of inflammatory 
cytokine, chemokines and growth factors. Although 
there is a distinct pathway between hypersensitivity 
and irritant reactions, a connecting network at mo-
lecular levels between both types of dermatitis 
contact seems to exist. This may be the reason why 
numerous similar epidermal cytokines have been in-
voleved in both hypersensitivity and irritant res-
ponses. The current state of the epidermal cytokines 
detected in irritant reactions or in compared to those 
in hyprsensitivity contact or delayed type hypersen-
sitivity in an in vivo model (cell-cultured keratino-
cytes) and an in vivo model (epidermis murine).15, 26, 
29-32 
    T-cell mediated immune reaction occuring after 
epicutaneous immunization and challenge with low 
molecular weight chemicals, i.e, hapten, which 
covalently bind to discreate amino acid residues on 
self or exogenous proteins. Hapten-modified protein 
could then be processed by APC into antigenic 
peptides, which are transported on the cell suface in 
association with class I or class II MHC molecules. 
Epidermal denritic cells, i.e, Langerhans cells (LCs) 
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play crucial role in the induction hypersensitivity 
contact. They capture the hapten (or hatenated 
protein) in the skin or mucosa and migrate to 
draining lymph nodes cells recognize a confor-
mational complex formed by hapten-modified pep-
tide within the groove of both MHC class I and class 
II DC molecules.14,19,34 
    The role of IL-4 has been reported by Bacharier 
et. al.34, that mice with targeted disruptions of the 
IL-4 gene. He concluded that IL-10 , but not IL-4 is 
natural supressant of irritan response as well as 
hypersensitivity contact. Indeed, IL-10 has been 
accepted widely as an inhibitor of  hypersensitivity 
contact, but not necessarily of irritant reaction. 
Recent data implied that IL-4 represented an im-
portant down-modulator of hypersensitivity contact, 
contra-dicting the findings by Bacharier et. al.34 
    Recently, mRNA for IL-14 and IFN-γ has been 
detected only in skin mice with hypersensitivity 
contact. Both IL-4 and IL-12 may be improtant 
cytokines in sensitivity contact. Presumably, IL-12 
may enhance or induce IL-2 and IFN-γ but inhibit 
IL-4 in pathogenesis of hypersensitivity contact, 
respectively.13, 30, 37 As IL-4 has been known to be a 
product of Th2 cells, its involement in hyper-
sensitivity contact may  probably tell us  that Th1  
cell cytokines  are not  solely  responsible  for  the  
development  of  sensitivity contact.34,36  
    If immunopathogenesis of oral mucosal tissue 
destruction in patients exposed to MMA happened 
through irritation, there would be significant upregu-
lated (p<0.05) plasma of TNF-α, without significant 
upregulated (p>0.05) of IL-4 and IFN-γ. However, 
the results of this study showed that there were 
significant upregulated plasma of TNF-α, IL-4 and 
IFN-γ. It can be concluded that immunopathoge-
nesis of oral mucosal tissue destruction in patients 
exposed to MMA does not happen through irrita-
tion. 
    The results of this study showed that there were 
significant upregulated (p<0.05) of plasma TNF-α 
and IFN-γ in patients exposed to MMA. It can be 
concluded that oral mucosal tissue destruction hap-
pened through type IV hypersensitivity reaction.  
    The conclusions of this study are MMA is immu-
nogenic in patients exposed to MMA that can in-
duce IgG anti-MMA. Immunopathogenesis of oral 
mucosal tissue destruction in patients exposed to 
MMA does not occur through irritation and type I 
hypersensitivity reaction mediated by IgE, but occur 
through type II and/or type III, type IV hypersen-
sitivity reactions.  
    The suggestion of this study is further study 
should be developed as a  diagnostic method for oral 
mucosal irritation and hypersensitivity reactions in 
patients exposed to MMA by assessing to oral mu-
cosa tissue that directly exposed to MMA and  
manifestation of hypersensitivity reaction.   
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